EPCAM and neoplasm: In this study, we investigated the specific delivery of designed ankyrin repeat proteins (DARPins) directed against human epidermal growth factor receptor 2 (HER2) or epithelial cell adhesion molecule (EpCAM) in complex 3D tumor microenvironments.